Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Genitourinary 1Breast 1

Conditions

Uterine Cervical Neoplasms 9Breast Neoplasms 4Papillomavirus Infections 3Prostatic Neoplasms 2Colorectal Neoplasms 2Rectal Neoplasms 1Overweight 1Obesity 1Lung Neoplasms 1Diabetes Mellitus 1Colonic Neoplasms 1

Interventions

Early Intervention, Educational 6Oxaliplatin 5Methods 4Cisplatin 4pembrolizumab 3Trastuzumab 3Surveys and Questionnaires 3Specimen Handling 3Leucovorin 3Fluorouracil 3Carboplatin 3X-Rays 2Radiotherapy 2Observation 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Irinotecan 2Interleukin-12 Subunit p35 2Gemcitabine 2Cyclophosphamide 2Counseling 2Cetuximab 2Capecitabine 2Biopsy 2veliparib 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Patient Navigation × Gynecologic × Clear all
NCT00379743 2018-04-26

Partnership for Healthy Seniors

Johns Hopkins Bloomberg School of Public Health

Phase NA Completed
2,593 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms, Colonic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡